Cite
A Preliminary Evaluation of Advanced Oxidation Protein Products (AOPPs) as a Potential Approach to Evaluating Prognosis in Early-Stage Breast Cancer Patients and Its Implication in Tumour Angiogenesis: A 7-Year Single-Centre Study.
MLA
Napiórkowska-Mastalerz, Marta, et al. “A Preliminary Evaluation of Advanced Oxidation Protein Products (AOPPs) as a Potential Approach to Evaluating Prognosis in Early-Stage Breast Cancer Patients and Its Implication in Tumour Angiogenesis: A 7-Year Single-Centre Study.” Cancers, vol. 16, no. 5, Mar. 2024, p. 1068. EBSCOhost, https://doi.org/10.3390/cancers16051068.
APA
Napiórkowska-Mastalerz, M., Wybranowski, T., Bosek, M., Kruszewski, S., Rhone, P., & Ruszkowska-Ciastek, B. (2024). A Preliminary Evaluation of Advanced Oxidation Protein Products (AOPPs) as a Potential Approach to Evaluating Prognosis in Early-Stage Breast Cancer Patients and Its Implication in Tumour Angiogenesis: A 7-Year Single-Centre Study. Cancers, 16(5), 1068. https://doi.org/10.3390/cancers16051068
Chicago
Napiórkowska-Mastalerz, Marta, Tomasz Wybranowski, Maciej Bosek, Stefan Kruszewski, Piotr Rhone, and Barbara Ruszkowska-Ciastek. 2024. “A Preliminary Evaluation of Advanced Oxidation Protein Products (AOPPs) as a Potential Approach to Evaluating Prognosis in Early-Stage Breast Cancer Patients and Its Implication in Tumour Angiogenesis: A 7-Year Single-Centre Study.” Cancers 16 (5): 1068. doi:10.3390/cancers16051068.